Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN Mayo Clinic
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Sociology graduate Addi Nunnelly applying lessons from the classroom in her work in the community
Nunnelly, a summa cum laude graduate at just 20 years old, exemplifies resilience, academic excellence and a passion for community impact.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN Mayo Clinic
LATEST NEWS
- Sociology graduate Addi Nunnelly applying lessons from the classroom in her work in the community
- New Doctor of Business Administration cohort features students with diverse professional backgrounds
- Biology graduate Julia Talbert working as research assistant at the Danforth Plant Science Center
- McDonnell Foundation supporting St. Louis Public Radio initiative to improve dialogue across differences
- UMSL receives $5.1 million grant to promote evidence-based literacy strategies in Missouri schools and area career centers
- New graduates celebrate their triumphs with family members, friends during fall 2024 commencement
- Language student Theresa Kallal finds meaning living life abroad in France and Spain
- College of Nursing receives funding from Missouri State Board of Nursing to develop new nurse educator certificate program
- Biology graduate Kordell Hamilton gains invaluable research experience while preparing to launch his career
- Mother-daughter duo graduates with same information systems capstone class
